Aqua Gen and Center for Integrative Genomics (CIGENE) Collaborate With Affymetrix (Santa Clara, California) on a Salmon Genotyping Array to Achieve the World's First High-Density View of the Marker Patterns in the Atlantic Salmon

ÅS, Norway & SANTA CLARA, Calif.--(BUSINESS WIRE)--Aqua Gen, a member of the Erich Wesjohann (EW) Group GmBH and Center for Integrative Genomics (CIGENE) at the Norwegian University of Life Sciences (UMB) in collaboration with Affymetrix, Inc. (NASDAQ: AFFX) announced today that they are the first to genotype more than 900,000 markers per sample from the Atlantic salmon (Salmo salar), thereby achieving the capability to implement genomic selection and improve their salmon breeding program at Aqua Gen. Aqua Gen, a leader in selective breeding, manages a large scale selective breeding program for Atlantic salmon, a major contributor to the world's aquaculture production. Aqua Gen has also been pioneering the use of marker-assisted selection in aquaculture breeding through their highly successful QTL-innOva products. CIGENE, located at the Norwegian University of Life Sciences, maintains research programs that contribute to the understanding of the biology of aquaculture and plant production, focusing in particular on the genetics of complex traits of economic and ecological significance. Aqua Gen and CIGENE partnered with Affymetrix to develop the salmon genotyping screening array which consists of 923,627 SNP (Single Nucleotide Polymorphism) markers and includes both diploid and tetraploid sequence variants. The goal of the ongoing study is to identify relevant and polymorphic high resolution markers that can be used downstream for marker trait association studies, genomic selection programs, as well as for a wide variety of applications in genetics and ecology.